Lilly(Eli) & Co [NYSE: LLY] jumped around 19.2 points on Wednesday, while shares priced at $619.13 at the close of the session, up 3.20%. The company report on November 8, 2023 at 4:56 PM that Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma.
Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares (“Shares”) of common stock of POINT Biopharma Global Inc. (NASDAQ: PNT), for a purchase price of $12.50 per share in cash, without interest and less any applicable tax withholding.
The tender offer, which was previously scheduled to expire at one minute past 11:59 p.m., Eastern time, on Nov. 9, 2023, has been extended until 5:00 p.m., Eastern time, on Nov. 16, 2023, unless the tender offer is further extended or earlier terminated, in order for the parties to satisfy outstanding closing conditions. The proposed acquisition is expected to close near the end of 2023, subject to customary closing conditions, including the tender of at least a majority of the outstanding Shares as of the expiration of the tender offer.
Lilly(Eli) & Co stock is now 69.24% up from its year-to-date (YTD) trading value. LLY Stock saw the intraday high of $625.87 and lowest of $592.18 per share. The company’s 52-week high price is 629.97, which means current price is +100.24% above from all time high which was touched on 10/13/23.
Compared to the average trading volume of 3.21M shares, LLY reached a trading volume of 7753605 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Lilly[Eli] & Co [LLY]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LLY shares is $622.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LLY stock is a recommendation set at 1.77. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Lilly(Eli) & Co shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 20, 2023.
The Average True Range (ATR) for Lilly(Eli) & Co is set at 18.98, with the Price to Sales ratio for LLY stock in the period of the last 12 months amounting to 18.33. The Price to Book ratio for the last quarter was 52.40, with the Price to Cash per share for the same quarter was set at 2.63. Price to Free Cash Flow for LLY in the course of the last twelve months was 180.62 with Quick ratio for the last quarter at 0.82.
How has LLY stock performed recently?
Lilly(Eli) & Co [LLY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.66. With this latest performance, LLY shares gained by 6.87% in over the last four-week period, additionally plugging by 42.03% over the last 6 months – not to mention a rise of 69.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LLY stock in for the last two-week period is set at 63.82, with the RSI for the last a single of trading hit 68.08, and the three-weeks RSI is set at 61.97 for Lilly(Eli) & Co [LLY]. The present Moving Average for the last 50 days of trading for this stock 573.08, while it was recorded at 592.47 for the last single week of trading, and 451.25 for the last 200 days.
Lilly[Eli] & Co [LLY]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Lilly(Eli) & Co [LLY] shares currently have an operating margin of +29.01 and a Gross Margin at +76.77. Lilly(Eli) & Co’s Net Margin is presently recorded at +21.88.
Return on Total Capital for LLY is now 31.22, given the latest momentum, and Return on Invested Capital for the company is 25.12. Return on Equity for this stock inclined to 63.63, with Return on Assets sitting at 12.71. When it comes to the capital structure of this company, Lilly(Eli) & Co [LLY] has a Total Debt to Total Equity ratio set at 152.48. Additionally, LLY Total Debt to Total Capital is recorded at 60.39, with Total Debt to Total Assets ending up at 32.81. Long-Term Debt to Equity for the company is recorded at 138.38, with the Long-Term Debt to Total Capital now at 54.81.
Reflecting on the efficiency of the workforce at the company, Lilly(Eli) & Co [LLY] managed to generate an average of $160,123 per employee. Receivables Turnover for the company is 3.42 with a Total Asset Turnover recorded at a value of 0.58.Lilly(Eli) & Co’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.82 and a Current Ratio set at 1.05.
Earnings analysis for Lilly(Eli) & Co [LLY]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LLY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lilly(Eli) & Co go to 25.76%.
Insider trade positions for Lilly[Eli] & Co [LLY]
The top three institutional holders of LLY stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2579%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $201.66 billion in LLY stocks shares; and BERKSHIRE HATHAWAY INC, currently with $177.59 billion in LLY stock with ownership which is approximately 5.7994%.